	Symptom clusters and network analysis in lung cancer patients receiving taxane-based chemotherapy: a comprehensive assessment using the CIPNAT multi-scale tool. Support Care Cancer Li T, Sun Q, Zhang M, Liu Z, Yao L, Wu Y, Ding M. PMID: 41840240 [PubMed - indexed for MEDLINE]
	Dual targeting of IGF-1R and K-RAS with natural phytochemicals for lung cancer therapy: an in-silico study. J Genet Eng Biotechnol Ahmed SF, Hossen Z, Chakraborty I, Rahman Munna MM, Chowdhury S, Zaheen A, Tasmin J, Ashraful ABM, Jahin MA, Ahmed MH. PMID: 41839684 [PubMed]
	Association of Immune-Related Adverse Events and the Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Adjusting for Immortal Time Bias. Thorac Cancer Kuwabara Y, Ohya H, Osawa M, Shiraishi K, Matsumoto I, Ishii S, Yokosuka S, Abe M, Takahashi T, Kawano Y, Nishimura H, Toda-Sasaki M, Kobayashi-Ogawa Y, Kikuchi S, Hirata Y, Sakai K, Kyoyama H, Moriyama G, Kawasaki Y, Koyama N, Uematsu K. PMID: 41839643 [PubMed - indexed for MEDLINE]
	Integrative multi-omics and experimental validation identify histone acetylation-related genes BCL9L, STX10 and LSM7 as key mediators of PD-1-driven immune evasion and prognosis in non-small cell lung cancer. Int Immunopharmacol Zhou J, Qiu T, Hu Z, Xiao D, Liu Z. PMID: 41839471 [PubMed - as supplied by publisher]
	Breast Cancer Combined with Primary Lung Cancer: A Study of Clinicopathologic Features and Prognostic Factors. J Vis Exp Song Y, Chen W, Shi M, Shao G, Zhang Y, Sun Z, Jin Z, Yu L. PMID: 41838757 [PubMed - indexed for MEDLINE]
	Can the current radiation dose, in chest tomosynthesis, be reduced with retained image quality? A study in the context of lung cancer screening programs. PLoS One Jadidi M, Svalkvist A, Båth M, Nyrén S. PMID: 41838727 [PubMed - indexed for MEDLINE]
	Eligibility criteria in phase 3 randomized controlled trials in metastatic non-small cell lung cancer. Cancer Borysowski J, K, Harhala M, Knetki-Wróblewska M, Krzakowski M. PMID: 41838447 [PubMed - indexed for MEDLINE]
	CT acquisition protocols in lung cancer screening: implications for guideline development from a worldwide survey. Insights Imaging Konrad MFG, Nischwitz E, Chorostowska-Wynimko J, Kerpel-Fronius A, Palm V, Moes-Sosnowska J, Adamek M, Zahlmann G, van der Lugt A, Vogel-Claussen J, Prosch H, Kauczor HU. PMID: 41838308 [PubMed]
	One needle, two diagnoses: a dual finding of adenocarcinoma and granulomatous reaction after EBUS-TBNA in lung cancer staging - a case report. Int J Surg Case Rep Diotti C, Lombardi M, Midolo de Luca V, Guarize J, Spaggiari L, Bertolaccini L. PMID: 41836974 [PubMed]
	Performance of latest AI models, RAG, and MCP on lung cancer-related questions. Digit Health Zhao X, Yang M, Tian K, Jiang H, Guo D, Wang Y, Du J. PMID: 41836629 [PubMed]
	The capability of deep-radiomics to predict pathological response to neoadjuvant immunochemotherapy in non-small cell lung cancer: a retrospective multicenter study. Front Immunol Ye Y, Tian Y, Wang L, Xi Z, Zhang Y, Zhou T, Zhao Z, Zheng Y, Liang X, Jiang H. PMID: 41836436 [PubMed - indexed for MEDLINE]
	Immune checkpoint inhibitor-related encephalitis overlapping with hyperprogression in metastatic lung cancer: a case report. Front Immunol Xu W, Cao B, Li X. PMID: 41836426 [PubMed - indexed for MEDLINE]
	CT-based intratumoral habitat and peritumoral radiomics model to predict spread through air spaces in solid lung adenocarcinoma with diameter â‰¤ 2 cm: a dual-center study. Front Oncol Shang G, Bian J, Wang P, Song Y, Zhao S, Dong N, Yuan Z, Peng X. PMID: 41836259 [PubMed]
	Myocardial injury after lung cancer surgery as a predictor of postoperative long-term mortality: A prospective cohort study. J Cardiovasc Thorac Res Protasov K, Barakhtenko O, Batunova E, Zubkov R, Ulybin P. PMID: 41836202 [PubMed]
	Development and Validation of a Predictive Model for Poor Pulmonary Rehabilitation Outcomes in Patients After Radical Lung Cancer Surgery. Ann Ital Chir Zhao S, He J, Sun H, Liu Y, Guo J, Huang H, Hu L. PMID: 41834551 [PubMed - indexed for MEDLINE]
	Non-Pharmacological Interventions for Cough in Patients With Lung Cancer: A Systematic Review and Meta-Analysis. J Clin Nurs Cao M, Cheng X, Lee VH, Lin CC, Cheung DST. PMID: 41834268 [PubMed - as supplied by publisher]
	Migration-adjusted lung cancer burden in China: a population data-based Bayesian spatial modeling approach. JNCI Cancer Spectr Hao S, Li G, Sun H, Du L, Zhang Y, Wang X, Wang T, Li Q. PMID: 41834133 [PubMed - as supplied by publisher]
	Tumor purity as a prognostic and predictive biomarker of postoperative radiotherapy outcomes in stage IIIA-N2 non-small-cell lung cancer: a transcriptomic analysis from the Lung ART trial. Int J Radiat Oncol Biol Phys Zrafi WS, Albarrán-Artahona V, Dall'Olio FG, Ghigna MR, Signolle N, Cozic N, Adam J, Lacroix L, Pechoux CL, Gautheret D, Besse B, Levy A. PMID: 41833910 [PubMed - as supplied by publisher]
	Long-term Analysis of One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 Trial. Int J Radiat Oncol Biol Phys Singh AK, Farrugia MK, Stephans KL, Bogart JA, Yu H, Groman A, Videtic GM. PMID: 41833909 [PubMed - as supplied by publisher]
	The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and PD-L1 Expression on Overall Survival in a Select Cohort from the IASLC 9(th) Edition Staging Database. J Thorac Oncol Yang SR, Tjota MY, Goren E, Giroux DJ, Galateau-Salle F, Husain AN, Kindler HL, Drazer MW, Aly R, Dycoco J, Mitchell O, Lechtenberg K, Travis WD, Rusch VW, Tsao MS, Sauter JL. PMID: 41833817 [PubMed - as supplied by publisher]

Articles 1 - 20 / 158127

Page 1 of 7907



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy